Hemostat Powder Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Hemostat Powder market size was valued at USD 397.6 million in 2022 and is forecast to a readjusted size of USD 537.5 million by 2029 with a CAGR of 4.4% during review period.

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares. North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%. The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%. Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.

This report is a detailed and comprehensive analysis for global Hemostat Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Hemostat Powder market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Hemostat Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Hemostat Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Hemostat Powder market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemostat Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Hemostat Powder market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Johnson & Johnson
   C. R. Bard
   Pfizer
   CSL Behring
   Gelita Medical
   Ferrosan Medical Devices
   Baxter
   Celox
   Equimedical
   Medira
   Biocer
   Hemostasis
   MBP

   Gelatin
   Fibrin
   Cellulose
   Others

   Surgical Wound Care
   General Wound Care

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Hemostat Powder Market in 2025?

The Hemostat Powder Market benefits from growing demand in surgical procedures due to its ability to control bleeding quickly and effectively. Innovations in product formulations and advancements in delivery systems make it a preferred choice in emergency and trauma care.

What weaknesses could impact the Hemostat Powder Market in 2025?

A major challenge is the relatively high cost of hemostat powders compared to traditional methods, which could limit their adoption in lower-resource healthcare settings. Additionally, the regulatory approval process can delay the introduction of new products into the market.

What opportunities exist for the Hemostat Powder Market in 2025?

There are significant opportunities in expanding the use of hemostat powders in emerging markets, where healthcare infrastructure is improving. The increasing prevalence of surgeries and traumatic injuries presents an expanding market. Also, growing awareness about the benefits of hemostat powders can drive adoption in both hospitals and outpatient settings.

What threats could affect the Hemostat Powder Market in 2025?

Intense competition from alternative hemostatic products, such as gels and seals, could limit market growth. Additionally, stringent regulatory policies and potential side effects related to the use of hemostat powders could deter some healthcare providers from adopting them.

What are the political factors influencing the Hemostat Powder Market in 2025?

Government regulations around medical device approvals and healthcare reimbursements significantly influence the market. Political stability in key markets can also impact the availability of raw materials and distribution channels for hemostat products.

How do economic factors affect the Hemostat Powder Market in 2025?

Economic conditions, especially in emerging markets, can impact the affordability and accessibility of hemostat powders. While hospitals in developed countries have budgets for advanced products, economic downturns or reduced healthcare spending may hinder the growth in some regions.

What social factors are driving the Hemostat Powder Market in 2025?

The increasing awareness of advanced surgical methods, along with a rising demand for minimally invasive procedures, is driving growth. Additionally, the aging population and the rise in trauma and surgical cases are contributing to the growing need for effective hemostatic solutions.

What technological factors are impacting the Hemostat Powder Market in 2025?

Advancements in biotechnology and material sciences are leading to the development of more effective and safer hemostat powders. Technologies enabling targeted drug delivery systems, along with improvements in the product’s speed of action, are key drivers in the market.

What environmental factors are relevant to the Hemostat Powder Market in 2025?

There is an increasing emphasis on sustainable and eco-friendly production methods. The environmental impact of manufacturing processes and disposal of medical products could drive innovation in biodegradable hemostatic products and environmentally conscious packaging.

What legal factors must be considered in the Hemostat Powder Market in 2025?

Regulatory frameworks for medical products are becoming more stringent. Manufacturers need to comply with international standards for safety, efficacy, and quality assurance. Failure to meet these legal requirements could result in delays in product launches or market access restrictions.

Who are the suppliers in the Hemostat Powder Market in 2025?

Suppliers include manufacturers of raw materials like biopolymers, chemicals, and active pharmaceutical ingredients, along with technology providers who enable the production of advanced hemostat powders. Additionally, packaging suppliers and logistics companies play a vital role in delivering the final product to healthcare providers.

What inputs are required for the Hemostat Powder Market in 2025?

Inputs include raw materials such as cellulose, collagen, and fibrin, which are crucial in the formulation of hemostat powders. Manufacturing technology, research & development for improving product efficacy, and regulatory compliance are also key inputs required to ensure the market’s growth and competitiveness.

What processes are involved in the Hemostat Powder Market in 2025?

The production process involves sourcing raw materials, formulating and testing the hemostatic powder, and ensuring compliance with medical standards. After that, the product undergoes packaging, distribution, and final delivery to healthcare institutions, hospitals, and trauma centers.

Who are the customers in the Hemostat Powder Market in 2025?

Customers include hospitals, trauma centers, surgical clinics, and healthcare providers who require effective bleeding control solutions for patients undergoing surgery or experiencing trauma. Additionally, government and private healthcare systems are also major customers for purchasing these products in bulk.

What are the desired outcomes in the Hemostat Powder Market in 2025?

The desired outcomes include the effective and rapid control of bleeding in surgical and trauma cases, increased adoption of hemostat powders in both developed and emerging markets, and improved patient outcomes. Manufacturers also aim to meet regulatory standards and expand their market share through innovation and product diversification.

How intense is the threat of new entrants in the Hemostat Powder Market in 2025?

The threat of new entrants is moderate. While there is potential for growth, the high cost of research, regulatory approvals, and the need for advanced manufacturing capabilities can create barriers to entry. Established companies with strong brands and regulatory expertise hold a competitive advantage.

What is the bargaining power of suppliers in the Hemostat Powder Market in 2025?

The bargaining power of suppliers is moderate. Although raw materials like biopolymers and chemicals are necessary, there are multiple suppliers available, which reduces the power of any single supplier. However, specialized suppliers with unique ingredients or technologies may exert higher bargaining power.

What is the bargaining power of buyers in the Hemostat Powder Market in 2025?

The bargaining power of buyers is moderate to high. Healthcare providers and hospitals, as the key customers, can influence prices through bulk purchasing and tenders. However, the clinical need for effective hemostatic solutions reduces the price sensitivity of these buyers to some extent.

How intense is the threat of substitute products in the Hemostat Powder Market in 2025?

The threat of substitutes is moderate. Alternative hemostatic products, such as gels, sponges, and seals, offer competition. However, the unique benefits of hemostat powders in certain surgical and trauma cases help reduce the likelihood of significant substitution in the near future.

How competitive is the rivalry among existing players in the Hemostat Powder Market in 2025?

Rivalry among existing players is high. The market is filled with established players and newer entrants vying for market share. Product differentiation, technological advancements, and cost-effectiveness are critical factors for maintaining competitive advantage, leading to fierce competition within the industry.

What are the key raw materials for the Hemostat Powder Market in 2025?

Key raw materials include biopolymers like cellulose, collagen, and fibrin, as well as synthetic materials and chemicals used to create hemostatic powders. These materials are essential for the formulation of effective and safe products.

How is the supply chain for raw materials structured in the Hemostat Powder Market in 2025?

The supply chain involves sourcing raw materials from specialized suppliers who provide biopolymers, chemicals, and other components. These materials are then processed and tested by manufacturers before being integrated into the production of hemostatic powders. The supply chain also includes logistics companies for product distribution to healthcare providers.

What challenges do suppliers face in the Hemostat Powder Market in 2025?

Suppliers face challenges such as fluctuating raw material costs, regulatory requirements, and the need for consistent product quality. The increasing demand for eco-friendly and biodegradable materials also puts pressure on suppliers to innovate and meet sustainability goals.

What is the role of technology in the upstream process of the Hemostat Powder Market in 2025?

Technology plays a crucial role in improving the quality and efficacy of raw materials, as well as in the development of advanced manufacturing processes. Innovations in biotechnology and material science are essential for creating more effective hemostatic powders that can meet the evolving needs of healthcare providers.

How do regulatory factors impact upstream operations in the Hemostat Powder Market in 2025?

Regulatory compliance is a significant factor, as manufacturers must adhere to stringent guidelines for product safety, efficacy, and quality. Obtaining the necessary certifications and approvals from regulatory bodies such as the FDA or EMA can delay production and increase costs for suppliers and manufacturers.

What processes are involved in the midstream phase of the Hemostat Powder Market in 2025?

The midstream phase involves the manufacturing, formulation, and quality control of hemostat powders. This includes transforming raw materials into finished products, testing for safety and efficacy, and ensuring compliance with regulatory standards. Packaging and labeling also occur during this phase.

How do manufacturers ensure product quality in the Hemostat Powder Market in 2025?

Manufacturers implement strict quality control measures throughout the production process, including sourcing high-quality raw materials, conducting rigorous testing for each batch, and adhering to Good Manufacturing Practices (GMP). Regulatory inspections and certifications further ensure product safety and reliability.

What role does research and development (R&D) play in the midstream phase?

R&D plays a vital role in developing innovative formulations and improving the effectiveness of hemostat powders. This includes enhancing the speed of action, making the powders more biodegradable, and improving their ability to control bleeding in various surgical and trauma scenarios.

What challenges do manufacturers face during the midstream phase?

Manufacturers face challenges such as maintaining consistency in product quality, managing production costs, and meeting regulatory requirements. Additionally, competition from alternative hemostatic products may push manufacturers to innovate continuously to stay ahead in the market.

How do distribution networks impact the midstream operations of the Hemostat Powder Market in 2025?

Efficient distribution networks are critical to ensuring that hemostat powders reach healthcare providers in a timely manner. Manufacturers rely on both local and international logistics channels to handle the storage, transportation, and delivery of products, which can impact product availability and lead times.

What is the role of healthcare providers in the downstream phase of the Hemostat Powder Market in 2025?

Healthcare providers, such as hospitals, trauma centers, and surgical clinics, are crucial in the downstream phase. They are the end-users of hemostat powders, using them in various medical procedures to control bleeding. Their feedback and usage patterns drive product demand and influence future market trends.

How do healthcare providers influence the adoption of hemostat powders?

Healthcare providers influence adoption through their decision-making on medical supplies. Factors like effectiveness, ease of use, cost, and patient outcomes play a significant role in their choice of hemostatic products. Clinical studies, peer recommendations, and patient safety considerations also impact their purchasing decisions.

What challenges do healthcare providers face with hemostat powders in 2025?

Healthcare providers face challenges like the high cost of hemostat powders, which may affect budget constraints, especially in resource-limited settings. Additionally, there may be concerns regarding product availability, shelf life, and the need for ongoing training to properly use these advanced products in complex medical situations.

How do distributors impact the downstream phase of the Hemostat Powder Market?

Distributors play a key role in ensuring the timely delivery of hemostat powders to healthcare providers. They manage the logistics and inventory, ensuring that products are stocked and available for urgent medical procedures. Effective distribution networks are essential for maintaining product availability and market reach.

What trends are influencing the downstream phase of the Hemostat Powder Market in 2025?

The growing trend of minimally invasive surgeries and trauma care is driving the demand for hemostat powders. Additionally, an increasing focus on patient safety and quicker recovery times is pushing healthcare providers to adopt advanced hemostatic solutions. There is also a shift toward personalized medicine, with hemostat powders being tailored to specific patient needs in some cases.

Chapter 1, to describe Hemostat Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemostat Powder, with price, sales, revenue and global market share of Hemostat Powder from 2018 to 2023.
Chapter 3, the Hemostat Powder competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostat Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hemostat Powder market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostat Powder.
Chapter 14 and 15, to describe Hemostat Powder sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Hemostat Powder
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Hemostat Powder Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Gelatin
       1.3.3 Fibrin
       1.3.4 Cellulose
       1.3.5 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Hemostat Powder Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Surgical Wound Care
       1.4.3 General Wound Care
   1.5 Global Hemostat Powder Market Size & Forecast
       1.5.1 Global Hemostat Powder Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Hemostat Powder Sales Quantity (2018-2029)
       1.5.3 Global Hemostat Powder Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Johnson & Johnson
       2.1.1 Johnson & Johnson Details
       2.1.2 Johnson & Johnson Major Business
       2.1.3 Johnson & Johnson Hemostat Powder Product and Services
       2.1.4 Johnson & Johnson Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Johnson & Johnson Recent Developments/Updates
   2.2 C. R. Bard
       2.2.1 C. R. Bard Details
       2.2.2 C. R. Bard Major Business
       2.2.3 C. R. Bard Hemostat Powder Product and Services
       2.2.4 C. R. Bard Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 C. R. Bard Recent Developments/Updates
   2.3 Pfizer
       2.3.1 Pfizer Details
       2.3.2 Pfizer Major Business
       2.3.3 Pfizer Hemostat Powder Product and Services
       2.3.4 Pfizer Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Pfizer Recent Developments/Updates
   2.4 CSL Behring
       2.4.1 CSL Behring Details
       2.4.2 CSL Behring Major Business
       2.4.3 CSL Behring Hemostat Powder Product and Services
       2.4.4 CSL Behring Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 CSL Behring Recent Developments/Updates
   2.5 Gelita Medical
       2.5.1 Gelita Medical Details
       2.5.2 Gelita Medical Major Business
       2.5.3 Gelita Medical Hemostat Powder Product and Services
       2.5.4 Gelita Medical Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Gelita Medical Recent Developments/Updates
   2.6 Ferrosan Medical Devices
       2.6.1 Ferrosan Medical Devices Details
       2.6.2 Ferrosan Medical Devices Major Business
       2.6.3 Ferrosan Medical Devices Hemostat Powder Product and Services
       2.6.4 Ferrosan Medical Devices Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Ferrosan Medical Devices Recent Developments/Updates
   2.7 Baxter
       2.7.1 Baxter Details
       2.7.2 Baxter Major Business
       2.7.3 Baxter Hemostat Powder Product and Services
       2.7.4 Baxter Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Baxter Recent Developments/Updates
   2.8 Celox
       2.8.1 Celox Details
       2.8.2 Celox Major Business
       2.8.3 Celox Hemostat Powder Product and Services
       2.8.4 Celox Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Celox Recent Developments/Updates
   2.9 Equimedical
       2.9.1 Equimedical Details
       2.9.2 Equimedical Major Business
       2.9.3 Equimedical Hemostat Powder Product and Services
       2.9.4 Equimedical Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Equimedical Recent Developments/Updates
   2.10 Medira
       2.10.1 Medira Details
       2.10.2 Medira Major Business
       2.10.3 Medira Hemostat Powder Product and Services
       2.10.4 Medira Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Medira Recent Developments/Updates
   2.11 Biocer
       2.11.1 Biocer Details
       2.11.2 Biocer Major Business
       2.11.3 Biocer Hemostat Powder Product and Services
       2.11.4 Biocer Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Biocer Recent Developments/Updates
   2.12 Hemostasis
       2.12.1 Hemostasis Details
       2.12.2 Hemostasis Major Business
       2.12.3 Hemostasis Hemostat Powder Product and Services
       2.12.4 Hemostasis Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Hemostasis Recent Developments/Updates
   2.13 MBP
       2.13.1 MBP Details
       2.13.2 MBP Major Business
       2.13.3 MBP Hemostat Powder Product and Services
       2.13.4 MBP Hemostat Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 MBP Recent Developments/Updates

3 Competitive Environment: Hemostat Powder by Manufacturer

   3.1 Global Hemostat Powder Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Hemostat Powder Revenue by Manufacturer (2018-2023)
   3.3 Global Hemostat Powder Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Hemostat Powder by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Hemostat Powder Manufacturer Market Share in 2022
       3.4.2 Top 6 Hemostat Powder Manufacturer Market Share in 2022
   3.5 Hemostat Powder Market: Overall Company Footprint Analysis
       3.5.1 Hemostat Powder Market: Region Footprint
       3.5.2 Hemostat Powder Market: Company Product Type Footprint
       3.5.3 Hemostat Powder Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Hemostat Powder Market Size by Region
       4.1.1 Global Hemostat Powder Sales Quantity by Region (2018-2029)
       4.1.2 Global Hemostat Powder Consumption Value by Region (2018-2029)
       4.1.3 Global Hemostat Powder Average Price by Region (2018-2029)
   4.2 North America Hemostat Powder Consumption Value (2018-2029)
   4.3 Europe Hemostat Powder Consumption Value (2018-2029)
   4.4 Asia-Pacific Hemostat Powder Consumption Value (2018-2029)
   4.5 South America Hemostat Powder Consumption Value (2018-2029)
   4.6 Middle East and Africa Hemostat Powder Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Hemostat Powder Sales Quantity by Type (2018-2029)
   5.2 Global Hemostat Powder Consumption Value by Type (2018-2029)
   5.3 Global Hemostat Powder Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Hemostat Powder Sales Quantity by Application (2018-2029)
   6.2 Global Hemostat Powder Consumption Value by Application (2018-2029)
   6.3 Global Hemostat Powder Average Price by Application (2018-2029)

7 North America

   7.1 North America Hemostat Powder Sales Quantity by Type (2018-2029)
   7.2 North America Hemostat Powder Sales Quantity by Application (2018-2029)
   7.3 North America Hemostat Powder Market Size by Country
       7.3.1 North America Hemostat Powder Sales Quantity by Country (2018-2029)
       7.3.2 North America Hemostat Powder Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Hemostat Powder Sales Quantity by Type (2018-2029)
   8.2 Europe Hemostat Powder Sales Quantity by Application (2018-2029)
   8.3 Europe Hemostat Powder Market Size by Country
       8.3.1 Europe Hemostat Powder Sales Quantity by Country (2018-2029)
       8.3.2 Europe Hemostat Powder Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Hemostat Powder Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Hemostat Powder Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Hemostat Powder Market Size by Region
       9.3.1 Asia-Pacific Hemostat Powder Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Hemostat Powder Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Hemostat Powder Sales Quantity by Type (2018-2029)
   10.2 South America Hemostat Powder Sales Quantity by Application (2018-2029)
   10.3 South America Hemostat Powder Market Size by Country
       10.3.1 South America Hemostat Powder Sales Quantity by Country (2018-2029)
       10.3.2 South America Hemostat Powder Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Hemostat Powder Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Hemostat Powder Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Hemostat Powder Market Size by Country
       11.3.1 Middle East & Africa Hemostat Powder Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Hemostat Powder Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Hemostat Powder Market Drivers
   12.2 Hemostat Powder Market Restraints
   12.3 Hemostat Powder Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Hemostat Powder and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Hemostat Powder
   13.3 Hemostat Powder Production Process
   13.4 Hemostat Powder Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Hemostat Powder Typical Distributors
   14.3 Hemostat Powder Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Hemostat Powder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Hemostat Powder Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
   Table 4. Johnson & Johnson Major Business
   Table 5. Johnson & Johnson Hemostat Powder Product and Services
   Table 6. Johnson & Johnson Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Johnson & Johnson Recent Developments/Updates
   Table 8. C. R. Bard Basic Information, Manufacturing Base and Competitors
   Table 9. C. R. Bard Major Business
   Table 10. C. R. Bard Hemostat Powder Product and Services
   Table 11. C. R. Bard Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. C. R. Bard Recent Developments/Updates
   Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
   Table 14. Pfizer Major Business
   Table 15. Pfizer Hemostat Powder Product and Services
   Table 16. Pfizer Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Pfizer Recent Developments/Updates
   Table 18. CSL Behring Basic Information, Manufacturing Base and Competitors
   Table 19. CSL Behring Major Business
   Table 20. CSL Behring Hemostat Powder Product and Services
   Table 21. CSL Behring Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. CSL Behring Recent Developments/Updates
   Table 23. Gelita Medical Basic Information, Manufacturing Base and Competitors
   Table 24. Gelita Medical Major Business
   Table 25. Gelita Medical Hemostat Powder Product and Services
   Table 26. Gelita Medical Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Gelita Medical Recent Developments/Updates
   Table 28. Ferrosan Medical Devices Basic Information, Manufacturing Base and Competitors
   Table 29. Ferrosan Medical Devices Major Business
   Table 30. Ferrosan Medical Devices Hemostat Powder Product and Services
   Table 31. Ferrosan Medical Devices Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Ferrosan Medical Devices Recent Developments/Updates
   Table 33. Baxter Basic Information, Manufacturing Base and Competitors
   Table 34. Baxter Major Business
   Table 35. Baxter Hemostat Powder Product and Services
   Table 36. Baxter Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Baxter Recent Developments/Updates
   Table 38. Celox Basic Information, Manufacturing Base and Competitors
   Table 39. Celox Major Business
   Table 40. Celox Hemostat Powder Product and Services
   Table 41. Celox Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Celox Recent Developments/Updates
   Table 43. Equimedical Basic Information, Manufacturing Base and Competitors
   Table 44. Equimedical Major Business
   Table 45. Equimedical Hemostat Powder Product and Services
   Table 46. Equimedical Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Equimedical Recent Developments/Updates
   Table 48. Medira Basic Information, Manufacturing Base and Competitors
   Table 49. Medira Major Business
   Table 50. Medira Hemostat Powder Product and Services
   Table 51. Medira Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Medira Recent Developments/Updates
   Table 53. Biocer Basic Information, Manufacturing Base and Competitors
   Table 54. Biocer Major Business
   Table 55. Biocer Hemostat Powder Product and Services
   Table 56. Biocer Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Biocer Recent Developments/Updates
   Table 58. Hemostasis Basic Information, Manufacturing Base and Competitors
   Table 59. Hemostasis Major Business
   Table 60. Hemostasis Hemostat Powder Product and Services
   Table 61. Hemostasis Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Hemostasis Recent Developments/Updates
   Table 63. MBP Basic Information, Manufacturing Base and Competitors
   Table 64. MBP Major Business
   Table 65. MBP Hemostat Powder Product and Services
   Table 66. MBP Hemostat Powder Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. MBP Recent Developments/Updates
   Table 68. Global Hemostat Powder Sales Quantity by Manufacturer (2018-2023) & (K MT)
   Table 69. Global Hemostat Powder Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 70. Global Hemostat Powder Average Price by Manufacturer (2018-2023) & (USD/MT)
   Table 71. Market Position of Manufacturers in Hemostat Powder, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 72. Head Office and Hemostat Powder Production Site of Key Manufacturer
   Table 73. Hemostat Powder Market: Company Product Type Footprint
   Table 74. Hemostat Powder Market: Company Product Application Footprint
   Table 75. Hemostat Powder New Market Entrants and Barriers to Market Entry
   Table 76. Hemostat Powder Mergers, Acquisition, Agreements, and Collaborations
   Table 77. Global Hemostat Powder Sales Quantity by Region (2018-2023) & (K MT)
   Table 78. Global Hemostat Powder Sales Quantity by Region (2024-2029) & (K MT)
   Table 79. Global Hemostat Powder Consumption Value by Region (2018-2023) & (USD Million)
   Table 80. Global Hemostat Powder Consumption Value by Region (2024-2029) & (USD Million)
   Table 81. Global Hemostat Powder Average Price by Region (2018-2023) & (USD/MT)
   Table 82. Global Hemostat Powder Average Price by Region (2024-2029) & (USD/MT)
   Table 83. Global Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 84. Global Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 85. Global Hemostat Powder Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Global Hemostat Powder Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Global Hemostat Powder Average Price by Type (2018-2023) & (USD/MT)
   Table 88. Global Hemostat Powder Average Price by Type (2024-2029) & (USD/MT)
   Table 89. Global Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 90. Global Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 91. Global Hemostat Powder Consumption Value by Application (2018-2023) & (USD Million)
   Table 92. Global Hemostat Powder Consumption Value by Application (2024-2029) & (USD Million)
   Table 93. Global Hemostat Powder Average Price by Application (2018-2023) & (USD/MT)
   Table 94. Global Hemostat Powder Average Price by Application (2024-2029) & (USD/MT)
   Table 95. North America Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 96. North America Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 97. North America Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 98. North America Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 99. North America Hemostat Powder Sales Quantity by Country (2018-2023) & (K MT)
   Table 100. North America Hemostat Powder Sales Quantity by Country (2024-2029) & (K MT)
   Table 101. North America Hemostat Powder Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. North America Hemostat Powder Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Europe Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 104. Europe Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 105. Europe Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 106. Europe Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 107. Europe Hemostat Powder Sales Quantity by Country (2018-2023) & (K MT)
   Table 108. Europe Hemostat Powder Sales Quantity by Country (2024-2029) & (K MT)
   Table 109. Europe Hemostat Powder Consumption Value by Country (2018-2023) & (USD Million)
   Table 110. Europe Hemostat Powder Consumption Value by Country (2024-2029) & (USD Million)
   Table 111. Asia-Pacific Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 112. Asia-Pacific Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 113. Asia-Pacific Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 114. Asia-Pacific Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 115. Asia-Pacific Hemostat Powder Sales Quantity by Region (2018-2023) & (K MT)
   Table 116. Asia-Pacific Hemostat Powder Sales Quantity by Region (2024-2029) & (K MT)
   Table 117. Asia-Pacific Hemostat Powder Consumption Value by Region (2018-2023) & (USD Million)
   Table 118. Asia-Pacific Hemostat Powder Consumption Value by Region (2024-2029) & (USD Million)
   Table 119. South America Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 120. South America Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 121. South America Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 122. South America Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 123. South America Hemostat Powder Sales Quantity by Country (2018-2023) & (K MT)
   Table 124. South America Hemostat Powder Sales Quantity by Country (2024-2029) & (K MT)
   Table 125. South America Hemostat Powder Consumption Value by Country (2018-2023) & (USD Million)
   Table 126. South America Hemostat Powder Consumption Value by Country (2024-2029) & (USD Million)
   Table 127. Middle East & Africa Hemostat Powder Sales Quantity by Type (2018-2023) & (K MT)
   Table 128. Middle East & Africa Hemostat Powder Sales Quantity by Type (2024-2029) & (K MT)
   Table 129. Middle East & Africa Hemostat Powder Sales Quantity by Application (2018-2023) & (K MT)
   Table 130. Middle East & Africa Hemostat Powder Sales Quantity by Application (2024-2029) & (K MT)
   Table 131. Middle East & Africa Hemostat Powder Sales Quantity by Region (2018-2023) & (K MT)
   Table 132. Middle East & Africa Hemostat Powder Sales Quantity by Region (2024-2029) & (K MT)
   Table 133. Middle East & Africa Hemostat Powder Consumption Value by Region (2018-2023) & (USD Million)
   Table 134. Middle East & Africa Hemostat Powder Consumption Value by Region (2024-2029) & (USD Million)
   Table 135. Hemostat Powder Raw Material
   Table 136. Key Manufacturers of Hemostat Powder Raw Materials
   Table 137. Hemostat Powder Typical Distributors
   Table 138. Hemostat Powder Typical Customers

List of Figures

   Figure 1. Hemostat Powder Picture
   Figure 2. Global Hemostat Powder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Hemostat Powder Consumption Value Market Share by Type in 2022
   Figure 4. Gelatin Examples
   Figure 5. Fibrin Examples
   Figure 6. Cellulose Examples
   Figure 7. Others Examples
   Figure 8. Global Hemostat Powder Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 9. Global Hemostat Powder Consumption Value Market Share by Application in 2022
   Figure 10. Surgical Wound Care Examples
   Figure 11. General Wound Care Examples
   Figure 12. Global Hemostat Powder Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Hemostat Powder Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Hemostat Powder Sales Quantity (2018-2029) & (K MT)
   Figure 15. Global Hemostat Powder Average Price (2018-2029) & (USD/MT)
   Figure 16. Global Hemostat Powder Sales Quantity Market Share by Manufacturer in 2022
   Figure 17. Global Hemostat Powder Consumption Value Market Share by Manufacturer in 2022
   Figure 18. Producer Shipments of Hemostat Powder by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 19. Top 3 Hemostat Powder Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Top 6 Hemostat Powder Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Global Hemostat Powder Sales Quantity Market Share by Region (2018-2029)
   Figure 22. Global Hemostat Powder Consumption Value Market Share by Region (2018-2029)
   Figure 23. North America Hemostat Powder Consumption Value (2018-2029) & (USD Million)
   Figure 24. Europe Hemostat Powder Consumption Value (2018-2029) & (USD Million)
   Figure 25. Asia-Pacific Hemostat Powder Consumption Value (2018-2029) & (USD Million)
   Figure 26. South America Hemostat Powder Consumption Value (2018-2029) & (USD Million)
   Figure 27. Middle East & Africa Hemostat Powder Consumption Value (2018-2029) & (USD Million)
   Figure 28. Global Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 29. Global Hemostat Powder Consumption Value Market Share by Type (2018-2029)
   Figure 30. Global Hemostat Powder Average Price by Type (2018-2029) & (USD/MT)
   Figure 31. Global Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 32. Global Hemostat Powder Consumption Value Market Share by Application (2018-2029)
   Figure 33. Global Hemostat Powder Average Price by Application (2018-2029) & (USD/MT)
   Figure 34. North America Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 35. North America Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 36. North America Hemostat Powder Sales Quantity Market Share by Country (2018-2029)
   Figure 37. North America Hemostat Powder Consumption Value Market Share by Country (2018-2029)
   Figure 38. United States Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Canada Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Mexico Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Europe Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 42. Europe Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 43. Europe Hemostat Powder Sales Quantity Market Share by Country (2018-2029)
   Figure 44. Europe Hemostat Powder Consumption Value Market Share by Country (2018-2029)
   Figure 45. Germany Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. France Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. United Kingdom Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Russia Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Italy Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Asia-Pacific Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 51. Asia-Pacific Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 52. Asia-Pacific Hemostat Powder Sales Quantity Market Share by Region (2018-2029)
   Figure 53. Asia-Pacific Hemostat Powder Consumption Value Market Share by Region (2018-2029)
   Figure 54. China Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Japan Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Korea Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. India Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Southeast Asia Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Australia Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. South America Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 61. South America Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 62. South America Hemostat Powder Sales Quantity Market Share by Country (2018-2029)
   Figure 63. South America Hemostat Powder Consumption Value Market Share by Country (2018-2029)
   Figure 64. Brazil Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Argentina Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Middle East & Africa Hemostat Powder Sales Quantity Market Share by Type (2018-2029)
   Figure 67. Middle East & Africa Hemostat Powder Sales Quantity Market Share by Application (2018-2029)
   Figure 68. Middle East & Africa Hemostat Powder Sales Quantity Market Share by Region (2018-2029)
   Figure 69. Middle East & Africa Hemostat Powder Consumption Value Market Share by Region (2018-2029)
   Figure 70. Turkey Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Egypt Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Saudi Arabia Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. South Africa Hemostat Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Hemostat Powder Market Drivers
   Figure 75. Hemostat Powder Market Restraints
   Figure 76. Hemostat Powder Market Trends
   Figure 77. Porters Five Forces Analysis
   Figure 78. Manufacturing Cost Structure Analysis of Hemostat Powder in 2022
   Figure 79. Manufacturing Process Analysis of Hemostat Powder
   Figure 80. Hemostat Powder Industrial Chain
   Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 82. Direct Channel Pros & Cons
   Figure 83. Indirect Channel Pros & Cons
   Figure 84. Methodology
   Figure 85. Research Process and Data Source